Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Scribed by Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tomino; Kenichi Yamada; Takeyuki Kitajima; Terukuni Ideura; Akio Koyama; Tetsuzo Sugisaki; Hiromichi Suzuki; Satoshi Umemura; Yoshindo Kawaguchi; Shunya Uchida; Michio Kuwahara; Tsutomu Yamazaki; for the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators

• Publisher: Springer
• Year: 2003
• Tongue: English
• Weight: 613 KB
• Volume: 7
• Category: Article
• ISSN: 1342-1751
• DOI: 10.1007/s10157-003-0241-3